- Home
- EHTH vs ACHV Comparison
EHTH vs ACHV Comparison
Compare EHTH & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ACHV
- Stock Information
- Founded
- EHTH 1997
- ACHV N/A
- Country
- EHTH United States
- ACHV Canada
- Employees
- EHTH N/A
- ACHV N/A
- Industry
- EHTH Specialty Insurers
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EHTH Finance
- ACHV Health Care
- Exchange
- EHTH Nasdaq
- ACHV Nasdaq
- Market Cap
- EHTH 153.5M
- ACHV 159.0M
- IPO Year
- EHTH 2006
- ACHV N/A
- Fundamental
- Price
- EHTH $4.78
- ACHV $4.25
- Analyst Decision
- EHTH Buy
- ACHV Strong Buy
- Analyst Count
- EHTH 3
- ACHV 5
- Target Price
- EHTH $7.33
- ACHV $14.80
- AVG Volume (30 Days)
- EHTH 214.4K
- ACHV 112.1K
- Earning Date
- EHTH 11-06-2024
- ACHV 11-07-2024
- Dividend Yield
- EHTH N/A
- ACHV N/A
- EPS Growth
- EHTH N/A
- ACHV N/A
- EPS
- EHTH N/A
- ACHV N/A
- Revenue
- EHTH $464,891,000.00
- ACHV N/A
- Revenue This Year
- EHTH $9.22
- ACHV N/A
- Revenue Next Year
- EHTH $6.32
- ACHV N/A
- P/E Ratio
- EHTH N/A
- ACHV N/A
- Revenue Growth
- EHTH 15.78
- ACHV N/A
- 52 Week Low
- EHTH $3.58
- ACHV $3.03
- 52 Week High
- EHTH $9.45
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- EHTH 46.70
- ACHV 35.58
- Support Level
- EHTH $5.14
- ACHV $4.32
- Resistance Level
- EHTH $5.42
- ACHV $4.75
- Average True Range (ATR)
- EHTH 0.32
- ACHV 0.23
- MACD
- EHTH -0.06
- ACHV -0.06
- Stochastic Oscillator
- EHTH 43.06
- ACHV 9.40
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.